NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

I think minimally that the company will be willing to breakup what they would charge for the entire set the vaccines. They are likely looking at charging for the first six vaccines (perhaps even as each is administered), and then charging for each additional vaccine when given.

Treatments were administered as follows: days 0, 10, 20, and at weeks 8, 16, 32, 48, 72, 96 and 120.

So the first three treatments would be given within the first month, and then at the 2 month mark, then the fourth month, then at the end of the year - thus in the first year, the patient would receive a total of six vaccines.

This type of fee arrangement does put the burden of initial cost onto the company (making profits likely somewhat small), but should the patient survive into the next year, then the cost of the vaccine is almost purely profit.

NICE may find some variation of this payment arrangement fits better with what they’re willing to pay.